SUPLEMENTAÇÃO DE VITAMINA D SOBRE OS DIFERENTES PARÂMETROS DA SÍNDROME METABÓLICA

Denise Cristine de  Oliveira; Bruna Batista dos  Santos; Débora Cristine Sicchieri; Maria Isabela Tiveron  Frizão; Taiane Priscila Gardizani

doi:10.69719/ros.v8.876

Autores

Denise Cristine de Oliveira Centro Universitário de Adamantina - FAI https://orcid.org/0000-0001-9343-573X
Bruna Batista dos Santos Centro Universitário de Adamantina - FAI https://orcid.org/0009-0009-7689-3267
Débora Cristine Sicchieri Centro Universitário de Adamantina - FAI https://orcid.org/0009-0005-8664-2358
Maria Isabela Tiveron Frizão Centro Universitário de Adamantina - FAI https://orcid.org/0009-0001-9284-8927
Taiane Priscila Gardizani Centro Universitário de Adamantina - FAI https://orcid.org/0000-0002-3903-334X

DOI:

https://doi.org/10.69719/ros.v8.876

Palavras-chave:

Suplementação, Vitamina D, Síndrome Metabólica

Resumo

A síndrome metabólica (SM) caracteriza-se por um conjunto de alterações metabólicas, incluindo obesidade central, dislipidemia, hipertensão arterial e resistência à insulina, de etiologia multifatorial. Nos últimos anos, tem crescido o número de casos de indivíduos com SM, o que tem estimulado a busca por métodos seguros e alternativos para o seu tratamento e prevenção. A vitamina D, um pró-hormônio lipossolúvel, que desempenha um papel essencial no metabolismo ósseo, tem se destacado também como um potente modulador de parâmetros metabólicos. Dessa maneira, o presente trabalho de revisão teve como objetivo reunir os principais estudos, publicados nos últimos dez anos (2025 a 2015), que avaliaram o impacto da suplementação de vitamina D, por diferentes períodos e doses, sobre cada um dos parâmetros da SM.

Referências

[1] Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z. PMID: 29480368; PMCID: PMC5866840. DOI: https://doi.org/10.1007/s11906-018-0812-z

[2] Faraji S, Alizadeh M. Efeitos mecanísticos da suplementação de vitamina D nos componentes da síndrome metabólica em pacientes com ou sem deficiência de vitamina D. Rev Obesid Síndr Metab. 2020;29(4):270.

[3] Sacerdote, A., Dave, P., Lokshin, V. et al. Diabetes Mellitus Tipo 2, Resistência à Insulina e Vitamina D. Curr Diab Rep 19 , 101 (2019). https://doi.org/10.1007/s11892-019-1201-y DOI: https://doi.org/10.1007/s11892-019-1201-y

[4] Argano C, Mirarchi L, Amodeo S, Orlando V, Torres A, Corrao S. The role of vitamin D and its molecular bases in insulin resistance, diabetes, metabolic syndrome, and cardiovascular disease: state of the art. Int J Mol Sci. 2023 Oct 23;24(20):15485. doi: 10.3390/ijms242015485 DOI: https://doi.org/10.3390/ijms242015485

[5] Raposo L, Martins S, Ferreira D, Guimarães JT, Santos AC. Vitamin D, parathyroid hormone and metabolic syndrome: the PORMETS study. BMC Endocr Disord. 2017 Nov 17;17(1):71. doi: 10.1186/s12902-017-0221-3. DOI: https://doi.org/10.1186/s12902-017-0221-3

[6] Theik NWY, Raji OE, Shenwai P, Shah R, Kalluri SR, Bhutta TH, Hannoodee H, Al Khalili M, Khan S. Relationship and Effects of Vitamin D on Metabolic Syndrome: A Systematic Review. Cureus. 2021 Aug 24;13(8):e17419. doi: 10.7759/cureus.17419. PMID: 34589329; PMCID: PMC8460559. DOI: https://doi.org/10.7759/cureus.17419

[7] Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92(6):2130–5. doi:10.1210/jc.2006-2250. DOI: https://doi.org/10.1210/jc.2006-2250

[8] Renke G, Starling-Soares B, Baesso T, Petronio R, Aguiar D, Paes R. Effects of vitamin D on cardiovascular risk and oxidative stress. Nutrients. 2023;15(3):769. doi: 10.3390/nu15030769. DOI: https://doi.org/10.3390/nu15030769

[9] Benedik E. Sources of vitamin D for humans. Int J Vitam Nutr Res. 2022 Mar;92(2):118-125. doi: 10.1024/0300-9831/a000733. Epub 2021 Oct 18. PMID: 34658250. DOI: https://doi.org/10.1024/0300-9831/a000733

[10] Santa K, Kumazawa Y, Nagaoka I. Prevention of metabolic syndrome by phytochemicals and vitamin D. Int J Mol Sci. 2023;24(3):2627. doi: 10.3390/ijms24032627 DOI: https://doi.org/10.3390/ijms24032627

[11] Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D supplementation, glycemic control, and insulin resistance in prediabetics: a meta-analysis. J Endocr Soc. 2018;2(7):687–709. doi:10.1210/js.2017-00472. DOI: https://doi.org/10.1210/js.2017-00472

[12] Elkhwanky MS, Wang X, Yin L, et al. Obesity represses CYP2R1, the vitamin D 25‐hydroxylase, in the liver and extrahepatic tissues. JBMR Plus. 2020;4(10):e10397 DOI: https://doi.org/10.1002/jbm4.10397

[13] Refaie A, Baldassini L, Mondillo C, De Vita M, Giglio E, Tarquini R, Gonnelli S, Caffarelli C. Vitamin D and Dyslipidemia: Is There Really a Link? A Narrative Review. Nutrients. 2024 Apr 12;16(8):1144. doi: 10.3390/nu16081144. PMID: 38674837; PMCID: PMC11053479. DOI: https://doi.org/10.3390/nu16081144

[14] Sharba ZF, Shareef RH, Abd BA, Hameed EN. Association between Dyslipidemia and Vitamin D Deficiency: a Cross-Sectional Study. Folia Med (Plovdiv). 2021 Dec 31;63(6):965-969. doi: 10.3897/folmed.63.e62417. PMID: 35851223 DOI: https://doi.org/10.3897/folmed.63.e62417

[15] Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017 Jul;109(2 Supl 1):1-76. Portuguese. doi: 10.5935/abc.20170121. Erratum in: Arq Bras Cardiol. 2017 Nov;109(5):499. doi: 10.5935/abc.20170159. PMID: 28813069. DOI: https://doi.org/10.5935/abc.20170159

[16] Padró T, Vilahur G, Badimon L. Dyslipidemias and Microcirculation. Curr Pharm Des. 2018;24(25):2921-2926. doi: 10.2174/1381612824666180702154129. PMID: 29968532. DOI: https://doi.org/10.2174/1381612824666180702154129

[17] Wang Y, Si S, Liu J, Wang Z, Jia H, Feng K, Sun L, Song SJ. The Associations of Serum Lipids with Vitamin D Status. PLoS One. 2016 Oct 21;11(10):e0165157. doi: 10.1371/journal.pone.0165157. PMID: 27768777; PMCID: PMC5074586 DOI: https://doi.org/10.1371/journal.pone.0165157

[18] Kim MR, Jeong SJ. Relationship between Vitamin D Level and Lipid Profile in Non-Obese Children. Metabolites. 2019 Jun 30;9(7):125. doi: 10.3390/metabo9070125. PMID: 31262034; PMCID: PMC6680594 DOI: https://doi.org/10.3390/metabo9070125

[19] Jiang X, Peng M, Chen S, Wu S, Zhang W. Vitamin D deficiency is associated with dyslipidemia: a cross-sectional study in 3788 subjects. Curr Med Res Opin. 2019 Jun;35(6):1059-1063. doi: 10.1080/03007995.2018.1552849. Epub 2019 Jan 7. PMID: 30479168. DOI: https://doi.org/10.1080/03007995.2018.1552849

[20] Alves AGP, Cruvinel BAC, Schincaglia RM, Godoi LS, Silva MS. Vitamin D supplementation reduces serum lipids of children with hypertriacylglycerolemia: A randomized, triple-masked, placebo-controlled crossover trial. Nutrition. 2021 Sep;89:111296. doi: 10.1016/j.nut.2021.111296. Epub 2021 Apr 28. PMID: 34116394. DOI: https://doi.org/10.1016/j.nut.2021.111296

[21] Yarparvar A, Elmadfa I, Djazayery A, Abdollahi Z, Salehi F, Heshmat R. The Effects of Vitamin D Supplementation on Lipid and Inflammatory Profile of Healthy Adolescent Boys: A Randomized Controlled Trial. Nutrients. 2020 Apr 25;12(5):1213. doi: 10.3390/nu12051213. PMID: 32344842; PMCID: PMC7282007. DOI: https://doi.org/10.3390/nu12051213

[22] Ghaderi A, Banafshe HR, Motmaen M, Rasouli-Azad M, Bahmani F, Asemi Z. Clinical trial of the effects of vitamin D supplementation on psychological symptoms and metabolic profiles in maintenance methadone treatment patients. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):84-89. doi: 10.1016/j.pnpbp.2017.06.016. Epub 2017 Jun 19. PMID: 28642082. DOI: https://doi.org/10.1016/j.pnpbp.2017.06.016

[23] Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients. 2019 Jan 17;11(1):188. doi: 10.3390/nu11010188. PMID: 30658483; PMCID: PMC6356309. DOI: https://doi.org/10.3390/nu11010188

[24] Barroso WKS, et al. Diretrizes Brasileiras de Hipertensão Arterial 2020. Arq Bras Cardiol. 2021;116(3):516-658. doi:10.36660/abc.20201238. DOI: https://doi.org/10.36660/abc.20201238

[25] Précoma DB, et al. Atualização da diretriz de prevenção cardiovascular da Sociedade Brasileira de Cardiologia-2019. Arq Bras Cardiol. 2019;113(4):787-891.

[26] Park D, Lee J, Park CY, Shin MJ. Low vitamin D status is associated with increased risk of mortality in Korean men and adults with hypertension: a population-based cohort study. Nutrients. 2022;14(9):1849. doi:10.3390/nu14091849. DOI: https://doi.org/10.3390/nu14091849

[27] Sheehy S, Palmer JR, Cozier Y, Bertrand KA, Rosenberg L. Vitamin D and risk of hypertension among Black women. J Clin Hypertens. 2023;25(2):168-174. doi:10.1111/jch.14615. DOI: https://doi.org/10.1111/jch.14615

[28] Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M, Orav EJ; DO-HEALTH Research Group. Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA. 2020;324(18):1855-1868. doi:10.1001/jama.2020.16909. PMID:33170239; PMCID:PMC7656284. DOI: https://doi.org/10.1001/jama.2020.16909

[29] Arora P, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2015;131(3):254-262 DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.011732

[30] Zelzer S, Meinitzer A, Enko D, Keppel MH, Herrmann M, Theiler-Schwetz V, et al. Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients. Nutrients. 2024 Mar 14;16(6):839. doi: 10.3390/nu16060839. PMID: 38542750; PMCID: PMC10975656. DOI: https://doi.org/10.3390/nu16060839

[31] Scragg R, Stewart AW, Waayer D, Lawes CMM, Toop L, Sluyter J, et al. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial. JAMA Cardiol. 2017 Jun 1;2(6):608-616. doi: 10.1001/jamacardio.2017.0175. PMID: 28384800; PMCID: PMC5815022. DOI: https://doi.org/10.1001/jamacardio.2017.0175

[32] Thompson B, Waterhouse M, English DR, McLeod DS, Armstrong BK, Baxter C, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023 Jun 28;381:e075230. doi: 10.1136/bmj-2023-075230. PMID: 37380191; PMCID: PMC10302209. DOI: https://doi.org/10.1136/bmj-2023-075230

[33] Sheikh V, Mozaianimonfared A, Gharakhani M, Poorolajal J, Ph D. Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency: a double-blind randomized clinical trial. J Clin Hypertens (Greenwich). 2020 Oct;22(10):1867-1873. doi: 10.1111/jch.13926. Epub 2020 Sep 20. PMID: 32951301; PMCID: PMC8030057. DOI: https://doi.org/10.1111/jch.13926

[34] Faria ACC, et al. Efeitos da suplementação de vitamina D sobre parâmetros hemodinâmicos centrais e sistema nervoso autônomo em indivíduos com obesidade ou sobrepeso. Arq Bras Cardiol. 2024;121(5):e20230678. DOI: https://doi.org/10.36660/abc.20230678i

[35] Ye H, Li Y, Liu S, et al. Association between serum 25-hydroxyvitamin D and vitamin D dietary supplementation and risk of all-cause and cardiovascular mortality among adults with hypertension. Nutr J. 2024;23:33. doi:10.1186/s12937-024-00914-8. DOI: https://doi.org/10.1186/s12937-024-00914-8

[36] Han L, Xu XJ, Zhang JS, Liu HM. Association between vitamin D deficiency and levels of renin and angiotensin in essential hypertension. Int J Clin Pract. 2022;2022:8975396. doi:10.1155/2022/8975396. DOI: https://doi.org/10.1155/2022/8975396

[37] Radulović Ž, Zupan ZP, Tomazini A, et al. Vitamin D in pediatric patients with obesity and arterial hypertension. Sci Rep. 2021;11:19591. doi:10.1038/s41598-021-98993-8. DOI: https://doi.org/10.1038/s41598-021-98993-8

[38] Si J, Li K, Shan P, et al. The combined presence of hypertension and vitamin D deficiency increased the probability of the occurrence of small vessel disease in China. BMC Neurol. 2019;19:164. doi:10.1186/s12883-019-1395-2. DOI: https://doi.org/10.1186/s12883-019-1395-2

[39] Mantzoros C, Natã D, Mulder J. Resistência à Insulina: Definição e Espectro Clínico. atualizado. com. 2015.

[40] de Oliveira INN, Macedo-Silva A, Coutinho-Cruz L, Sanchez-Almeida J, Tavares MPS, Majerowicz D. Effects of vitamin D supplementation on metabolic syndrome parameters in patients with obesity or diabetes in Brazil, Europe, and the United States: a systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2024;106582. doi:10.1016/j.jsbmb.2023.106582. DOI: https://doi.org/10.1016/j.jsbmb.2024.106582

[41] Dominoni LADC, Gabiatti MP, Piazza FR, Streb AR, Del Duca GF, Hansen F. Vitamin D is associated with body composition and fat intake, but not with cardiometabolic parameters in adults with obesity. Nutr Res. 2022;105:97-104. doi:10.1016/j.nutres.2022.02.006. DOI: https://doi.org/10.1016/j.nutres.2022.06.006

[42] Duggan C, de Dieu Tapsoba J, Mason C, Imayama I, Korde L, Wang CY, McTiernan A. Effect of vitamin D3 supplementation in combination with weight loss on inflammatory biomarkers in postmenopausal women: a randomized controlled trial. Cancer Prev Res (Phila). 2015;8(7):628–635. doi:10.1158/1940-6207.CAPR-15-0031. DOI: https://doi.org/10.1158/1940-6207.CAPR-14-0449

[43] Perna S, et al. Is vitamin D supplementation useful for weight loss programs? A systematic review and meta-analysis of randomized controlled trials. Medicina (Kaunas). 2019;55(7):368. doi:10.3390/medicina55070368. DOI: https://doi.org/10.3390/medicina55070368

[44] Pludowski P, Marcinowska-Suchowierska E, Togizbayev G, Belaya Z, Grant WB, Pilz S, Holick MF. Daily and Weekly "High Doses" of Cholecalciferol for the Prevention and Treatment of Vitamin D Deficiency for Obese or Multi-Morbidity and Multi-Treatment Patients Requiring Multi-Drugs-A Narrative Review. Nutrients. 2024 Aug 3;16(15):2541. doi: 10.3390/nu16152541. PMID: 39125420; PMCID: PMC11314300. DOI: https://doi.org/10.3390/nu16152541

[45] Chattranukulchai Shantavasinkul P, Nimitphong H. Vitamin D and Visceral Obesity in Humans: What Should Clinicians Know? Nutrients. 2022 Jul 27;14(15):3075. doi: 10.3390/nu14153075. PMID: 35893929; PMCID: PMC9332747. DOI: https://doi.org/10.3390/nu14153075

[46] Memic-Inan C, Sökülmez-Kaya P, Akar S. Frequency of vitamin D deficiency in patients with lumbar spinal stenosis and its relationship with obesity, depression, and pain intensity: a cross-sectional study. Rev Nutr. 2022;35:e220020. doi:10.1590/1678-9865202235e220020. DOI: https://doi.org/10.1590/1678-9865202235e220020

[47] Pourshahidi LK. Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc. 2015;74(2):115-124. doi:10.1017/S0029665114001578. DOI: https://doi.org/10.1017/S0029665114001578

[48] Pérez-Bravo F, Duarte L, Arredondo-Olguín M, Iñiguez G, Castillo-Valenzuela O. Vitamin D status and obesity in children from Chile. Eur J Clin Nutr. 2022;76(6):899-901. doi:10.1038/s41430-021-01050-6. DOI: https://doi.org/10.1038/s41430-021-01043-9

[49] Zhao J, Fu S, Chen Q. Association between the serum vitamin D level and prevalence of obesity/abdominal obesity in women with infertility: a cross-sectional study of the National Health and Nutrition Examination Survey data. Gynecol Endocrinol. 2023;39(1):2217251. doi:10.1080/09513590.2022.2151871. DOI: https://doi.org/10.1080/09513590.2023.2217251

[50] Bosdou JK, Konstantinidou E, Anagnostis P, Kolibianakis EM, Goulis DG. Vitamin D and obesity: two interacting players in the field of infertility. Nutrients. 2019;11(7):1455. doi:10.3390/nu11071455. DOI: https://doi.org/10.3390/nu11071455

[51] Al-Sofiani ME, Jammah A, Racz M, Khawaja RA, Hasanato R, El-Fawal HA, Mason DL. Effect of vitamin D supplementation on glucose control and inflammatory response in type II diabetes: a double blind, randomized clinical trial. Int J Endocrinol Metab. 2015;13(1):e21405. doi:10.5812/ijem.21405. DOI: https://doi.org/10.5812/ijem.22604

[52] Alfredsson L, Armstrong BK, Butterfield DA, Chowdhury R, de Gruijl FR, Feelisch M, Young AR. Insufficient sun exposure has become a real public health problem. Int J Environ Res Public Health. 2020;17(14):5014. doi:10.3390/ijerph17145014. DOI: https://doi.org/10.3390/ijerph17145014

[53] Rajakumar K, Moore CG, Khalid AT, Vallejo AN, Virji MA, Holick MF, Greenspan SL, Arslanian S, Reis SE. Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D-deficient overweight and obese children: a randomized clinical trial. Am J Clin Nutr. 2020 Apr 1;111(4):757-768. doi: 10.1093/ajcn/nqz340. PMID: 31950134; PMCID: PMC7138671. DOI: https://doi.org/10.1093/ajcn/nqz340

[54] Bassatne A, Chakhtoura M, Saad R, Fuleihan GEH. Vitamin D supplementation in obesity and during weight loss: a review of randomized controlled trials. Metabolism. 2019;92:193-205. doi:10.1016/j.metabol.2018.11.011. DOI: https://doi.org/10.1016/j.metabol.2018.12.010

[55] Qi KJ, Zhao ZT, Zhang W, Yang F. The impacts of vitamin D supplementation in adults with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2022;13:1033026. doi:10.3389/fphar.2022.1033026. DOI: https://doi.org/10.3389/fphar.2022.1033026